Cookie Settings
This site uses cookies to store information on your computer, to improve your experience. One of the cookies this site uses is essential for parts of the site to operate and has already been set. You may delete and block all cookies from this site, but parts of the site will not work. To find out more about the cookies this site uses and how to delete them, please see the privacy notice.
skip to main content
Home > Services > Research > Research and Development > Previous Studies

Previous Studies

Here is a list of studies we have done in the past. These are no longer running but provide a glimpse of the research that has been undertaken within SHFT. 

  • DigiMedSA Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System with Healthcare Professionals and Adult Subjects with Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic.
  • TRDA questionnaire study for those with depression that is not responding to treatment.
  • AppRoVEEvaluating the psychotic properties of new measures of responding to distressing voices and other people.
  • DFENDA randomised, double blind, placebo controlled parallel group trial of vitamin D supplementation compared to placebo in people presenting with their First Episode of psychosis (DFEND).
  • STRATIFYA study interested in understanding the connections between certain behaviours such as low motivation, negative emotions, difficulties with attention, alcohol use, eating disorders and unusual experiences regarding Mental illness.
  • EMHePA questionnaire study looking at how patients and mental health service professionals value service quality and outcomes of mental healthcare.
  • LightMind2A study looking at whether self-help books for depression can be helpful.
  • TRIumPHTreatment and Recovery in Psychosis is an evaluation of the benefits of a new care pathway for people who have experienced psychosis. Its research aim is to identify if it is possible to implement a psychosis pathway based on principles of early access to services and interventions and whether it is acceptable to patients and staff. The evaluation will be used to improve the services that people receive.
  • RegainA twenty-six week, randomized, open-label, 2-arm parallel group real world pragmatic trial to assess the clinical and health outcomes benefit of transition to Toujeo compared to standard of care insulin, in basal insulin treated patients with uncontrolled type 2 diabetes mellitus, with six-month extension
  • Address 2A study to establish a cohort of people with Type 1 Diabetes and their siblings to further research in this area.
Page Comments